LTBR identified as potential target for cancer immunotherapy and marker of poor prognosis

  • Post author:
  • Post category:uncategorized

A new research paper was published in Aging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US” by Web of Science) Volume 16, Issue 1, entitled, “Systematic analysis of the prognostic value and immunological function of LTBR in human cancer.”